SCHEMBL3698441

SCHEMBL3698441

CC(O)(COc1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2746561 1.00 AR (1.00) AR
SCHEMBL14086825 1.00 AR (1.00) AR
SCHEMBL12706742 0.92 AR (0.85) AR
SCHEMBL14252926 0.92 AR (0.85) AR
SCHEMBL12453355 0.91 AR (0.83) AR
SCHEMBL10364518 0.91 AR (0.83) AR
SCHEMBL2689756 0.91 AR (1.00) AR
SCHEMBL16871452 0.91 AR (1.00) AR
SCHEMBL12451560 0.91 AR (0.83) AR
SCHEMBL14086827 0.91 AR (0.83) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2276496-B1 THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION UNIV CALIFORNIA (US) 2019-07-10 EP claimed
US-9138457-B2 Therapeutic modulation of ocular surface lubrication THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-09-22 US claimed
WO-2009137602-A1 THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-11-12 WO claimed
WO-2020160452-A1 COMBINING SERMS, SARMS, AND CANNABINOIDS FOR IMPROVING SAFETY AND EFFICACY OF ENDOCRINE THERAPIES TESS VENTURES, INC. (US) 2020-08-06 WO disclosed
EP-2276497-B1 OPHTHALMIC DEVICE, AND METHOD OF USE THEREOF, FOR INCREASING OCULAR BOUNDARY LUBRICATION UNIV CALIFORNIA (US) 2020-04-22 EP disclosed
EP-2276496-B1 THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION UNIV CALIFORNIA (US) 2019-07-10 EP disclosed
EP-2464375-B1 PRG4 TREATMENT FOR INTERSTITIAL CYSTITIS LUBRIS LLC (US) 2017-06-14 EP disclosed
US-9138457-B2 Therapeutic modulation of ocular surface lubrication THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-09-22 US disclosed
US-9107885-B2 PRG4 treatment for interstitial cystitis LUBRIS LLC (US) 2015-08-18 US disclosed
US-8980840-B2 Therapeutic modulation of vaginal epithelium boundary lubrication SCHEPENS EYE RESEARCH INSTITUTE (US) 2015-03-17 US disclosed
US-8945604-B2 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-02-03 US disclosed
EP-2381957-B1 THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM BOUNDARY LUBRICATION LUBRIS LLC (US) 2015-01-07 EP disclosed
US-20140099343-A1 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication SCHEPENS EYE RESEARCH INSTITUTE (US) 2014-04-10 US disclosed
US-8563028-B2 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-22 US disclosed
US-20120321693-A1 PRG4 TREATMENT FOR INTERSTITIAL CYSTITIS LUBRIS LLC 2012-12-20 US disclosed
EP-2464375-A2 PRG4 TREATMENT FOR INTERSTITIAL CYSTITIS Singularis Inc. (US) 2012-06-20 EP disclosed
CN-102438645-A Therapeutic modulation of vaginal epithelial interfacial lubrication SINGULARIS INC 2012-05-02 CN disclosed
WO-2010083239-A2 THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM BOUNDARY LUBRICATION TRUITT EDWARD R III (US) 2010-07-22 WO disclosed
WO-2009137602-A1 THERAPEUTIC MODULATION OF OCULAR SURFACE LUBRICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-11-12 WO disclosed
WO-2009137603-A1 OPHTHALMIC DEVICE, AND METHOD OF USE THEREOF, FOR INCREASING OCULAR BOUNDARY LUBRICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-11-12 WO disclosed